On ECHEMI
Home > Drugs > Nanjing Pharmaceutical FACTORY Co., Ltd.
Nanjing Pharmaceutical FACTORY Co., Ltd.
  • Founded in:

    1991-07-11
  • Country:

    China China
  • Address:

    No. 26, Xingang Avenue, Nanjing Economic and Technological Development Zone
  • Tax NO.:

    91320192134908655F
  • Registered Funds:

    200.8 million yuan
  • Website:

  • Email:

Related Drugs
Zoledronic acid
Name Description Content CAS NO. Registered Holders
Zoledronic acid

Extract from the above information

More

Extract from the above information

118072-93-8 37
Zoledronic Acid for Injection
The main ingredient of this product is zoledronic acid, and its chemical name is 2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid monohydrate
Name Description Content CAS NO. Registered Holders
Zoledronic acid

Inhibition of bone resorption may be related to multiple effects: it can inhibit osteoclast activity in vitro, induce osteoclast apoptosis, block osteoclast absorption of mineralized bone and cartilage by binding to bones, and inhibit the enhanced osteoclast activity and bone calcium release caused by various stimulating factors released by tumors.

More

Inhibition of bone resorption may be related to multiple effects: it can inhibit osteoclast activity in vitro, induce osteoclast apoptosis, block osteoclast absorption of mineralized bone and cartilage by binding to bones, and inhibit the enhanced osteoclast activity and bone calcium release caused by various stimulating factors released by tumors.

118072-93-8 37
Oxaliplatin
Oxaliplatin
Name Description Content CAS NO. Registered Holders
Oxaliplatin

61825-94-3 56
Azasetron Hydrochloride Injection
The main ingredient of this product is azasetron hydrochloride
Name Description Content CAS NO. Registered Holders
AZASETRON HYDROCHLORIDE

Selective 5-HT3 receptor antagonist, has a significant inhibitory effect on nausea and vomiting caused by anticancer drugs such as cisplatin

More

Selective 5-HT3 receptor antagonist, has a significant inhibitory effect on nausea and vomiting caused by anticancer drugs such as cisplatin

141922-90-9 7
Azasetron Hydrochloride
Name Description Content CAS NO. Registered Holders
AZASETRON HYDROCHLORIDE

Extract from the above information

More

Extract from the above information

141922-90-9 7
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.